Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities:
Net loss	$ (939,947,000)	$ (547,496,000)	$ (471,341,000)
Reconciliation of net loss to net cash used in operating activities:
Stock-based compensation	8,176,000	19,602,000	5,622,000
Amortization of debt discount	1,734,000	1,474,000	373,000
Allowance for note receivable	8,357,000	0	0
Depreciation and amortization	88,878,000	7,285,000	699,000
Amortization of right-of-use asset	10,235,000	4,463,000	2,576,000
Inventory write down	233,929,000	0	0
Change in fair value measurements	327,823,000	0	0
Change in fair value of warrants liability	0	0	138,436,000
Unrealized loss recognized on equity securities	1,791,000	6,860,000	0
Unrealized (gain) loss on foreign currency transactions	5,947,000	3,975,000	(1,469,000)
Changes in operating assets and liabilities:
Inventory	(636,156,000)	0	0
Accounts receivable	(17,528,000)	0	0
Deferred revenue	45,555,000	0	0
Prepaid expenses and other assets	(33,442,000)	(53,194,000)	(43,797,000)
Accounts payable and accrued expenses	205,471,000	99,578,000	66,253,000
Customer deposits	26,677,000	9,034,000	2,773,000
Change in operating lease liability	(6,431,000)	(4,118,000)	(1,395,000)
Net cash used in operating activities	(668,931,000)	(452,537,000)	(301,270,000)
Cash Flows from Investing Activities:
Acquisition of equity investment	0	(10,000,000)	0
Funding of notes receivable	(8,357,000)	0	0
Purchase of property and equipment and intangible asset	(227,587,000)	(190,989,000)	(134,386,000)
Net cash used in investing activities	(235,944,000)	(200,989,000)	(134,386,000)
Cash Flows from Financing Activities:
Proceeds from issuance of convertible notes	450,000,000	0	667,500,000
Payments for debt issuance costs	25,000	0	(209,000)
Payments made for capped call options	0	0	(96,788,000)
Payments made to initial purchasers for convertible notes	0	0	(8,314,000)
Proceeds from exercise of warrants	0	0	89,023,000
Payments for stock issuance costs and redemption of unexercised warrants	0	0	(22,000)
Payments of finance lease obligations	(18,303,000)	0	0
Payments to tax authorities for statutory withholding taxes	(63,000)	(1,562,000)	(9,869,000)
Proceeds from the exercise of stock options	(26,000)	2,154,000	5,616,000
Proceeds from stock issuance under “At-the-market” offering	135,928,000	190,492,000	0
Payments for “At-the-market” issuance costs	(1,867,000)	(3,448,000)	0
Net cash provided by financing activities	565,694,000	187,636,000	646,937,000
Effect of exchange rate changes on cash	(1,469,000)	0	0
Net increase (decrease) in cash and cash equivalents, and restricted cash	(340,650,000)	(465,890,000)	211,281,000
Cash and cash equivalents, and restricted cash, beginning of the period	736,549,000	1,202,439,000	991,158,000
Cash and cash equivalents and restricted cash, end of the period	395,899,000	736,549,000	1,202,439,000
Cash and cash equivalents, beginning of period	736,549,000	1,202,439,000	991,158,000
Restricted cash, beginning of period	0	0	0
Cash and cash equivalents	325,452,000	736,549,000	1,202,439,000
Restricted cash	70,447,000	0	0
Supplemental disclosure of cash flow information
Cash paid for interest	16,688,000	17,985,000	0
Cash paid for income taxes	$ 338,000	$ 46,000	$ 0